Nordson Corporation · NASDAQ:NDSN
Nordson — Investor Presentation (April 2025)
39 slides from Nordson's investor presentation, Apr 15, 2025
Slide 1: Investor Presentation
Investor Presentation April 15, 2025 Nasdaq: NDSN NBS NEXT OWNER MINDSET WINNING TEAMS
Slide 2: Safe Harbor Statement
Safe Harbor Statement Click to edit title Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by
Slide 3: Nordson is a growth compounder with unique competitive advantages
Nordson is a growth compounder with unique competitive advantages Company Founded 2024 Revenue 2024 EBITDA% Employees Countries with Direct Presence 1954 $2.7B 32% 8,000+ 35+ 3
Slide 4: By the Numbers
By the Numbers Demonstrated Consistent Record Disciplined focus Differentiated Consistent value to Value to Solid Returns of Growth on profitability Product Portfolio* shareholders Customers 6% 55% 30% 13% 2,100+ 61 yrs. Sales Growth Gross Margins EBITDA Margins Global Patents of Annual ROIC Held Di
Slide 5: Diversified Sources of Sales
Diversified Sources of Sales FY2024 Profile - $2.7 Billion Product Type Geographies 29% Parts and Americas 42% Consumables 44% Europe 58% Systems Asia Pacific 27% High percentage of recurring Diversified geographic footprint. sales from parts and Direct presence in over consumables. 35 countries. 5
Slide 6: Diversified End Markets
Diversified End Markets Medical Electronics Consumer Non-Durable Industrial Remaining Markets 27% of revenue 25% of revenue 21% of revenue 14% of revenue 13% of revenue Balloons, extrusions, delivery Semiconductor packaging Box sealing Construction and industrial catheters and other minimall
Slide 7: How We Are Organized
How We Are Organized INDUSTRIAL PRECISION SOLUTIONS MEDICAL FLUID SOLUTIONS ADVANCED TECHNOLOGY SOLUTIONS Adhesives, Industrial Coatings, Interventional Solutions, Fluid Components Electronic Processing Systems Measurement and Control Solutions & Polymer Processing Systems & Engineered Fluid Dispens
Slide 8: Industrial Precision Solutions (IPS)
Industrial Precision Solutions (IPS) What we do: Product lines reduce material consumption, increase line efficiency, and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This business primarily serves the in
Slide 9: IPS End Markets
IPS End Markets % of Revenue / Applications / Growth Rates CONSUMER NONDURABLE INDUSTRIAL OTHER 40% of IPS Sales 35% of IPS Sales 25% of IPS Sales Corrugated and carton packaging Industrial manufacturing machinery Consumer durable (appliance / wood) Food and beverage packaging Plastic proc
Slide 10: Medical Fluid Solutions (MFS)
Medical Fluid Solutions (MFS) What we do: Fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips, and fluid connection components are used to dispense or control fluids within customers’ medi
Slide 11: MFS End Markets
MFS End Markets % of Revenue / Applications / Growth Rates SPECIALTY MEDICAL MINIMALLY INVASIVE SURGICAL INDUSTRIAL TECHNOLOGY 40% of MFS Sales 36% of MFS Sales 24% of MFS Sales Surgical, ECMO, Biopharma, Patient Cardiovascular, Structural Heart, Electronics and Wireless, EV, Industrial, Care, Anima
Slide 12: Advanced Technology Solutions
Advanced Technology Solutions What we do: Design and develop proprietary technologies found in progressive stages of an electronics customer’s production processes, such as surface treatment, precisely controlled dispensing of material and test, inspection and measurement to ensure quality and relia
Slide 13: ATS End Markets
ATS End Markets % of Revenue / Applications / Growth Rates SEMICONDUCTORS AUTOMOTIVE ELECTRONICS GENERAL ELECTRONICS 50% of ATS Sales 14% of ATS Sales 36% of ATS Sales Process control for wafer processing PCBA inspection and metrology for PCBA inspection and metrology for Wafer level and chi
Slide 14: Why Invest in Nordson?
CNordson Why Invest in Nordson?
Slide 15: A Growth Portfolio Ready to Accelerate
A Growth Portfolio Ready to Accelerate 2014 (FY Revenue $1.7B) 2024 (FY Revenue $2.7B) 39% Systems 43% Systems Parts / Service 58% Parts / Service 61% Growth Growth 29% End Markets 52% End Markets 13% 24% 23% 25% Electronics 14% 6% Medical 5% Nondurables 21% 27% 42% Industrial 15 Other *Percentage m
Slide 16: 2025-2029 Financial Targets
2025-2029 Financial Targets Growth Compounder Revenue Adjusted EPS Growth Growth 6-8% 10-12% Average annual growth Engaged Employees Driven by Nordson Values 16
Slide 17: Driving profitable growth by selecting and investing disproportionately in the best growth opportunities
Driving profitable growth by selecting and investing disproportionately in the 17 best growth opportunities
Slide 18: Entrepreneurial division-led organization
Entrepreneurial division-led organization: Decisions close to the customer Autonomy + Accountability Clear line of sight to deploying NBS Next 18
Slide 19: A key ingredient to successful execution of the Ascend strategy
A key ingredient to successful execution of the Ascend strategy: Leaders inspiring trust and building followership in the organization Focus on inclusion and diversity in everything we do Create an engaging culture that attracts and retains top talent 19
Slide 20: Disciplined Approach to M&A
Disciplined Approach to M&A Strategic Criteria Financial Criteria Serving attractive end market niches and Growth at or above market rates with Nordson- applications like gross margins Differentiated product technologies/solutions EBITDA ~20+% with margin expansion opportunities Additive
Slide 21: Growth Algorithm
Growth Algorithm Revenue Adjusted EPS 3% - 4% 4% 6%-8% $2.7B 3% - 4% 10%-12% $9.73 6% - 8% 2024 Organic M&A 2029 2024 Incremental Profit NBS Next 2029 21
Slide 22: Superior Conversion / Deployment of Cash Flows
Superior Conversion / Deployment of Cash Flows Generation of ~ $4.1B in operating cash flows through 2029 Capital Deployment through 2029 Cash Flow Deployment Priorities Fund organic growth 7% Return to shareholders thru dividends and Organic Capital routine stock repurchases to offset dilution
Slide 23: Recent Financial Results
CNorison Recent malatclalerts) Results
Slide 24: Total Company – 1Q 2025
Total Company – 1Q 2025 1Q 2025 Sales Bridge** Sales $633 $53 Reported sales of $615M, a decrease of 3%, at the $615 low end of prior guidance range $(11) $(59) 8% growth from the Atrion acquisition; unfavorable currency impact of 2% 9% organic decrease driven by weakness in polymer processing
Slide 25: Balance Sheet and Cash Flow
Balance Sheet and Cash Flow Balanced Capital Deployment Returning Value to Shareholders Net Debt Free Cash Flow* Cash totaled $130 million Cash flow of $138 million, which is a conversion rate of 146% of net income, deployed toward: 2.4x net debt leverage ratio based on trailing 12-month o Sha
Slide 26: 2Q Fiscal 2025 Guidance
2Q Fiscal 2025 Guidance 2Q 2025 Sales Guidance $650 - $690 Steady performance moving into 2Q $650 $651 Historical seasonality and order entry trends support moderate increases in sales and earnings sequentially Backlog grew by ~$85 million or 15% in the first quarter, ending at approximately $67
Slide 27: 2025 Fiscal Full-Year Guidance
2025 Fiscal Full-Year Guidance Full-year Sales Guidance Full-Year Growth from Record 2024 $2,750 - $2,870 Ascend strategy is advancing and delivering results Backlog, including Atrion, is ~$670 million as of 1/31/25 $2,689 $2,629 Fiscal 2025 sales growth of 2% to 7%, inclusive of FX headwind o
Slide 28: Appendix 1: Product Innovation
Appendix 1: Product Innovation
Slide 29: Our Electronics Industry Position
Our Electronics Industry Position Surface Mount Manufacturing Solder paste Flux spray Optical Inline Systems Plasma Underfill, Optical X-ray Conformal inspection coating inspection surface encapsulation inspection inspection coating treatment or precise coating Solder paste Component placement Reflo
Slide 30: Our Role in the Semiconductor Process
Our Role in the Semiconductor Process 30
Slide 31: CyberOptics expands market opportunities
CyberOptics expands market opportunities Nordson T&I Division CyberOptics Optical Sensors & Systems 3D Optical semi market expected to grow ~15%+, 31 exceeding the broader ‘Wafer Fab Equipment’ market LSD ’23 – ’25 growth
Slide 32: Medical and Fluid Solutions
Medical and Fluid Solutions Fluid Solutions Interventional Solutions Fluid Components Precision Low-Volume Dispensing Medical balloons, catheters, cannulas Single-use components From benchtop dispensers to industry-best From specialty tubing, catheters, medical Proprietary single-use plastic jetting
Slide 33: Core Adhesives Innovative Technology
Core Adhesives Innovative Technology Auto-fill Tankless Variable Dispense Foaming Jetting Precision dispense Technology Technology Technology Technology technology Adhesive fill systems Delivering different Maintains bond strength Dispenses adhesive Increases production monitor and maintain add-on r
Slide 34: Appendix 2: Financial Exhibits
Appendix 2: Financial Exhibits
Slide 35: Non-GAAP Definitions
Appendix Non-GAAP Definitions This presentation contains references to non-GAAP financial information. Although these are non-GAAP measures, we believe that they are useful to an investor in evaluating the company performance for the period presented. These non-GAAP definitions include: EBITDA is
Slide 36: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Net Income to Adjusted EBITDA (Dollars in thousands) 36
Slide 37: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Adjusted Operating Profit and EBITDA (Dollars in thousands) 37
Slide 38: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Profitability (Dollars in thousands) 38
Slide 39: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Operating Cash Flow to Free Cash Flow 39